Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetated Ringer’s solution in experimental hypovolemia
2023-503946-30-00Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ringer's acetate in hypovolemia (2 arms), sponsored by Oslo University Hospital. Primary endpoint: Half-life of cardiac stroke volume relative to baseline. Started Jun 2023; status: completed.
02
Drugs
ringer's acetate
03
Conditions
hypovolemia
Beyond the preview
Go deeper on 2023-503946-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503946-30-00.